ClinicalTrials.gg
CompletedNCT07454434Anxiety SleepUpdated Nov 10, 2026

The Effect of Music on Anxiety Levels and Sleep Quality in Patients Who Have a Myocardial Infarction

An interventional study of Music intervention in Sleep Quality and Anxiety, sponsored by Mersin University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Mersin University · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 10, 2026Now CompletedFirst site in Turkey (Türkiye)+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Sleep Initiation and Maintenance Disorders by Mersin University — 4 open to participants now, 4 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Mersin University.

Enrollment
4th of 11
64 · median 62
Started
2025
with 3 others
No phase
11 of 11
4 open now
Registered
9th of 11
by date

Among the 11 studies in Sleep Initiation and Maintenance Disorders by Mersin University, this one is the 4th largest by enrollment, is one of 4 that started in 2025, is one of 11 with no phase, and was the 9th registered.

Sleep Initiation and Maintenance Disorders

2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

4 of the 11 studies in Sleep Initiation and Maintenance Disorders by Mersin University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Sleep Initiation and Maintenance Disorders by Mersin University, or all of them as a file.
02

Study summary

Music therapy is a non-invasive method with no side effects and can be administered independently by a nurse. Nevertheless, it should be noted that music therapy can be discontinued if any adverse effects are experienced by patients during the research process. After completing the music listening session, eye masks and earplugs, which are effective in reducing sleep problems in patients, will be applied from 11:00 p.m. to 7:00 a.m.

All patients will be asked to complete the DAÖ at 10:00 PM and 10:30 PM. The RCUÖ will be requested to be completed by all patients between 8:00 AM and 9:00 AM the following morning.

Read the detailed description

Control Group: Patients in the control group will receive routine treatment and care in the coronary care unit (CCU). Patients presenting with MI are admitted to the coronary care unit from the emergency department and the cardiology outpatient clinic. In patients admitted to the CCU, preparations are made for percutaneous coronary intervention (PCI) and admission procedures by evaluating electrocardiography (ECG), blood parameters (CK-MB and troponin), and pain symptoms. These preparations include obtaining the patient's medical history and necessary consent, establishing an intravenous line, measuring and monitoring vital signs, and recording the ECG and adding it to the file. In patients undergoing PCI, the femoral sheath is not removed for four hours due to the heparin infusion administered. After the femoral sheath is removed by the physician, pressure dressing is applied to the procedure site and a sandbag is placed to control bleeding for six hours. During this time, patients are placed in a supine position. Depending on the clinical condition and hematological values of the patients, they are monitored in the coronary care unit for one or two days and then transferred to the cardiology clinic.

In the coronary care unit, in order to control patients' anxiety levels or improve their sleep quality, after care, treatment, and daily blood sampling procedures are completed, lighting is reduced after midnight, except in emergencies, to facilitate patients' transition to sleep. However, eye masks or earplugs are not routinely used for patients.

Study Group: In addition to the clinic's routine treatment and care practices, patients in the study group will listen to music for 30 minutes at 10:00 p.m. on their first night in the coronary care unit using wireless Bluetooth headphones (JBL TUNE 520BT, Harman International Industries, USA) provided by the researcher (MY). The volume of the music will be adjusted according to the patient's preference. Patients in the study will listen to the CD "Music and Health Series: Tümata-Receptive \& Meditative Uşşak Mode" prepared by the Turkish Music Research and Promotion Association (TÜMATA), which is said to provide calmness and relaxation and has previously been shown to be effective in reducing preoperative anxiety. The Uşşak mode has a tempo of 60-80 beats per minute and provides relaxation by calming the heart. The CD used contains an instrumental piece without lyrics in the Uşşak mode, which fits the definition of "sedative music". The piece features improvisation based on rhythm and the sound of water, performed with the ney, rebab, çeng, ud, dombra, and rubab. In addition to evoking a sense of peace and tranquility, the Uşşak mode supports feelings of self-confidence and determination thanks to its hidden pentatonic structure . The Uşşak mode is reported to give individuals a desire to laugh, a feeling of relaxation, joy, strength, and heroism; it is also reported to be beneficial for sleep and rest processes. Its effect is said to be particularly pronounced from dawn to noon, at sunset, and on Thursdays; it is also said to be beneficial in alleviating pain associated with heart and foot disorders and gout. Furthermore, it is known as one of the oldest modes used to express deep love and mystical feelings .

03

Conditions studied

  • Sleep Quality
  • Anxiety

Keywords

  • music listening
  • nursing
  • sleep
  • anxiety
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Admitted to the coronary care unit with a diagnosis of MI,
  • Aged 18 years or older,
  • Conscious, oriented, and cooperative,
  • Able to read and understand Turkish,
  • Agreeing to participate in the study,
  • Having no physical condition that would prevent listening to music,
  • Having no diagnosis of hearing loss,
  • Not using a hearing aid,
  • Having no diagnosis of anxiety disorder,
  • Not diagnosed with a sleep disorder,
  • Not taking medication for anxiety or sleep disorders,
  • Without mental illness,
  • With a State Anxiety Scale (SAS) total score of 60 or below,
  • Who agree to participate in the study (by signing the Form) will be included.

Exclusion criteria

Exclusion Criteria:

  • Admitted to the coronary care unit (CCU) for reasons other than MI diagnosis,
  • Under 18 years of age,
  • Unconscious, disoriented, and uncooperative,
  • Unable to read and understand Turkish,
  • Refusing to participate in the study,
  • Having a physical condition that prevents listening to music,
  • Diagnosed with hearing loss,
  • Using a hearing aid,
  • Diagnosed with an anxiety disorder or taking medication for anxiety,
  • Diagnosed with a sleep disorder or taking medication for a sleep disorder,
  • With a mental disorder,
  • With a State Anxiety Scale (SAS) total score of 60 or above,
  • Patients who do not agree to participate in the study (who do not sign the Form) will not be included in the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
64 participants (actual)

Study arms

  • No intervention
    Control

    Control Group: Patients in the control group will receive routine treatment and care in the coronary care unit (CCU). Patients with MI are admitted to the coronary care unit from the emergency department and the cardiology outpatient clinic. In patients admitted to the care unit, preparations are made for percutaneous coronary intervention (PCI) and admission procedures by evaluating electrocardiography (ECG), blood parameters (CK-MB and Troponin), and pain symptoms. These preparations include obtaining the patient's medical history and necessary consent, establishing an intravenous line, measuring and monitoring vital signs, and recording the ECG and adding it to the file. In patients undergoing PCI, the femoral sheath is not removed for four hours due to the heparin infusion administered. After the femoral sheath is removed by the physician, pressure dressing is applied to the procedure site and a sandbag is placed to control bleeding for six hours. During this time, patients are pl

  • Experimental
    Music Group

    Patients included in the study group will be played music at 10:00 PM on their first night in the Coronary Care Unit (CCU) for 30 minutes using wireless Bluetooth headphones (JBL TUNE 520BT, Harman International Industries, USA) by the researcher (MY), in addition to the clinic's routine treatment and care practices. The volume of the music will be adjusted according to the patient's preference. Patients in the study will listen to the CD "Music and Health Series: Tümata-Receptive \& Meditative Uşşak Mode" from the Turkish Music Research and Promotion Association (TÜMATA), which is said to provide calmness and relaxation and has previously been shown to be effective in reducing preoperative anxiety . The Uşşak mode has a tempo of 60-80 beats per minute and provides relaxation by calming the heart . The CD used contains an instrumental piece without lyrics in the Uşşak mode, which fits the definition of "sedative music" . The piece features improvisation based on rhythm

    Other: Music intervention

Interventions

  • OtherMusic intervention

    Music therapy is a non-invasive method with no side effects and can be administered independently by a nurse. However, it should be noted that music therapy may be discontinued if any adverse effects are observed in patients during the research process. After completing the music therapy, eye masks and earplugs , which are effective in reducing sleep problems in patients, will be applied from 11:00 p.m. to 7:00 a.m.

06

What researchers measure

Primary outcomes

  1. Participants' anxiety levels

    In this study, the State-Trait Anxiety Inventory (STAI) developed by Spielberger and colleagues will be used to measure feelings experienced at the moment. The adaptation of the State-Trait Anxiety Inventory into Turkish, as well as its validity and reliability studies, were conducted by Öner and Le Comte. The scale consists of the SSI, which determines how an individual feels at a particular moment and under specific conditions, and the State Anxiety Scale (SAS), which determines how an individual feels regardless of their current situation and conditions. State anxiety is the fear felt by an individual due to stressful situations they are in and is an indicator of the individual's feelings of tension and unease . The response options in the SSI are grouped into four classes: (1) Not at all, (2) A little, (3) Very much, and (4) Completely. There are two types of statements in the SAD. These are (1) direct or straightforward and (2) reverse statements.

    Time frame: Within the State Anxiety Scale framework, the study group will receive 30 minutes of music at 22:00 on their first night in the Coronary Intensive Care Unit, alongside routine care, via wireless Bluetooth headphones under researcher supervision.

Secondary outcomes

  1. Sleep Quality

    In this study, the RCUÖ , developed by Richards in 1987, will be used to measure the sleep quality of patients during their first night in the coronary care unit. The scale consists of 6 items that assess the depth of nighttime sleep, the time it takes to fall asleep, the frequency of waking up, the time spent awake after waking up, the quality of sleep, and the noise level in the environment. Each item is evaluated using the visual analog scale technique, on a scale from 0 to 100. On the scale, scores between "0-25" indicate very poor sleep, while scores between "76-100" indicate very good sleep. The sixth item on the scale, which assesses environmental noise, is excluded from the total score assessment, and the total scale score is calculated based on the five items. As the scale score increases, patients' sleep quality improves. The Cronbach α value of the original scale was found to be 0.82, and the Turkish validity and reliability study was conducted by Karaman

    Time frame: The Richard-Campbell Sleep Questionnaire will be administered to all patients between 08:00 and 09:00 on the morning following their first night of hospitalization.

07

Study locations

1 site
  • Mersin University
    Mersin, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2025 to primary completion in Aug 2026, 7 months.

Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's 7 months is below that.

Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: start Feb 2026 → Dec 2025 and primary completion Mar 2026 → Aug 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 10, 2025
First posted
Mar 6, 2026
StartActual
Dec 5, 2025was Feb 2026
Primary completionActual
Aug 1, 2026was Mar 2026
CompletionActual
Aug 1, 2026
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Nov 10, 2026
Sites
1 site added — first site in Turkey (Türkiye)
Show site
  • Mersin University · Mersin, Turkey (Türkiye)
Nov 10, 2026
Start date
Feb 23, 2026→Dec 5, 2025 (actual)
Nov 10, 2026
Primary completion
Mar 15, 2026→Aug 1, 2026 (actual)
Nov 10, 2026
Study completion
Aug 30, 2026→Aug 1, 2026 (actual)
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Not yet recruiting→Completed
    1 site added — first site in Turkey (Türkiye)
    Show site
    • Mersin University · Mersin, Turkey (Türkiye)
    Start date Feb 23, 2026→Dec 5, 2025 (now actual)
    Primary completion Mar 15, 2026→Aug 1, 2026 (now actual)
    Study completion Aug 30, 2026→Aug 1, 2026 (now actual)
    + 3 other changes: verification date, oversight details and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07454434
Lead sponsor
Mersin University
Responsible party
Meryem Yesil (graduate student, Mersin University) — Principal investigator
First posted
Mar 6, 2026
Start date
Dec 5, 2025
Primary completion
Aug 1, 2026
Completion
Aug 1, 2026
Last update
Nov 10, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion